Agomab News, Agomab Quote, AGMB Quote

Agomab (NQ:AGMB) Delayed: 13.21 +0.53 (4.18%)

Prev. Close

$12.68

Today 6M 1Y 5Y

Open

$12.75

52 Wk High

$0.01

52 Wk Low

$0.01

Day High

$13.51

Day Low

$12.36

P/E

N/A

EPS

$0.00

Volume

42,459

ALERTS | RSS

Jun 23, 2026 04:14 PM Form 6-K Agomab Therapeutics NV For: Jun 23
Jun 23, 2026 04:05 PM Agomab outlines Phase 2b trial design for Crohn's disease drug
Jun 23, 2026 04:05 PM Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
Jun 22, 2026 06:07 AM H.C. Wainwright Starts Agomab Therapeutics (AGMB) at Buy
May 27, 2026 07:12 AM Form 6-K Agomab Therapeutics NV For: May 27
May 27, 2026 05:00 AM Agomab Announces Results of Annual General Meeting
May 27, 2026 05:00 AM Agomab Announces Results of Annual General Meeting
May 15, 2026 04:49 PM Form SCHEDULE 13G Agomab Therapeutics NV Filed by: Redmile Group, LLC
May 15, 2026 01:15 PM Form SCHEDULE 13G Agomab Therapeutics NV Filed by: Cormorant Asset Management, LP
May 14, 2026 07:30 AM Agomab to Participate in Upcoming Conferences

Entities mentioned with AGMB

View All Entities